Omeros (OMER) Retained Earnings (2010 - 2026)
Omeros' (OMER) quarterly Retained Earnings came in at -$857.6 million in Q1 2026, up 9.13% year-on-year from -$785.9 million in Q1 2025, and up 6.14% quarter-over-quarter from -$913.7 million in Q4 2025.
Omeros (OMER) Retained Earnings (2010 - 2026) Analysis & Trends
Omeros has disclosed Retained Earnings across 17 years of filings, most recently posting -$857.6 million for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$857.6 million, up 9.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$857.6 million (up 9.13% YoY), and the FY2025 annual result was -$913.7 million, changed 0.37% from the prior year.
- Retained Earnings came in at -$857.6 million for Q1 2026 at Omeros, up from -$913.7 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$635.7 million in Q4 2022 to a low of -$1.0 billion in Q3 2025.
- The 5-year median for Retained Earnings is -$790.7 million (2024), against an average of -$814.6 million.
- Across the five-year window, Retained Earnings rose 21.51% in 2022 and slipped 20.81% in 2024, its largest moves.
- Omeros' Retained Earnings stood at -$635.7 million in 2022, then retreated by 18.53% to -$753.5 million in 2023, then decreased by 20.81% to -$910.3 million in 2024, then retreated by 0.37% to -$913.7 million in 2025, then rose by 6.14% to -$857.6 million in 2026.
- The last three Retained Earnings figures came in at -$857.6 million (Q1 2026), -$913.7 million (Q4 2025), and -$1.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | -857.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -857.64 Mn |
| Dec 31, 2025 | -913.70 Mn |
| Sep 30, 2025 | -1.00 Bn |
| Jun 30, 2025 | -969.23 Mn |
| Mar 31, 2025 | -943.81 Mn |
| Dec 31, 2024 | -910.35 Mn |
| Sep 30, 2024 | -878.99 Mn |
| Jun 30, 2024 | -846.76 Mn |
| Mar 31, 2024 | -790.71 Mn |
| Dec 31, 2023 | -753.53 Mn |
| Sep 30, 2023 | -744.46 Mn |
| Jun 30, 2023 | -706.71 Mn |
| Mar 31, 2023 | -669.42 Mn |
| Dec 31, 2022 | -635.72 Mn |
| Sep 30, 2022 | -764.45 Mn |
| Jun 30, 2022 | -746.99 Mn |
| Mar 31, 2022 | -716.15 Mn |
| Dec 31, 2021 | -683.13 Mn |
| Sep 30, 2021 | -963.76 Mn |
| Jun 30, 2021 | -941.05 Mn |